ALPAU
Get informed when a big investor buys or sells
+ Follow| Market cap | $24.13 Million |
|---|---|
| Enterprise Value | $24.42 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.83 |
| Beta | 0 |
| Outstanding Shares | 2,475,321 |
| P/E Ratio | -2.08 |
|---|---|
| PEG | 1246.85 |
| Price to Sales | - |
| Price to Book Ratio | -2.44 |
| Enterprise Value to Revenue | 14.48 |
| Enterprise Value to EBIT | -5.76 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | -0.04 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tib...